Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Processa Pharmaceuticals Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Processa Pharmaceuticals Inc. July 30, 2026100.0%
-
Endovia Health Sciences Inc. October 31, 202593.6%
-
Processa Pharmaceuticals Inc. July 18, 2025100.0%
-
Endovia Health Sciences Inc. November 15, 202490.4%
-
Processa Pharmaceuticals Inc. June 28, 2024100.0%
-
Endovia Health Sciences Inc. October 6, 202399.4%
-
Processa Pharmaceuticals Inc. June 27, 2023100.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 26, 2026 | Processa Pharmaceuticals Inc. | Option exercise | +203 | — | — |
| Jan 27, 2025 | Processa Pharmaceuticals Inc. | Open-market purchase | +12,400 | $0.80 | $9,920 |
| Jan 30, 2024 | Processa Pharmaceuticals Inc. | Open-market purchase | +8,000 | $2.69 | $21,520 |
| Nov 21, 2023 | Processa Pharmaceuticals Inc. | Other | −55,267 | — | — |
| Oct 12, 2023 | Processa Pharmaceuticals Inc. | Grant or award | +6,000 | $0.30 | $1,800 |
| Oct 10, 2023 | Processa Pharmaceuticals Inc. | Grant or award | +12,000 | $0.21 | $2,520 |
| Jun 27, 2023 | Processa Pharmaceuticals Inc. | Option exercise | +23,636 | — | — |
| Dec 31, 2022 | Processa Pharmaceuticals Inc. | Grant or award | +18,208 | — | — |
Questions about Justin W. Yorke
What boards is Justin W. Yorke on?
Justin W. Yorke sits on the boards of Endovia Health Sciences Inc. and Processa Pharmaceuticals Inc.
How long has Justin W. Yorke served on boards?
Our records show at least 7 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.